Écrit par THERADIAG | 21 Janvier 2015

Succès du repositionnement stratégique de la Société



· Ventes en théranostic : x 3,6 à 1,4 million d'euros

· Accélération des ventes de produits in house : +26%, 61% du CA total

· Développement soutenu des ventes à l'international : 41% du CA total

· Forte hausse des ventes de produits de biologie moléculaire : +63%

 

 

Croissy-Beaubourg et Montpellier, le 20...

Écrit par BONE THERAPEUTICS | 17 Janvier 2015

Gosselies, Belgium, 16 January 2015 - BONE THERAPEUTICS, the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, announces today its intention to raise new funds through an Initial Public Offering on Euronext Brussels and Euronext Paris.

HighlightsBone Therapeutics is a leader in bone cell therapySince it was...

Écrit par GlobalData | 13 Janvier 2015

LONDON, UK (GlobalData), 13 January 2015 - The medical device industry witnessed an all-time record high in terms of deal valuations in 2014, with a total of 96 mergers and acquisitions (M&As) announced, representing an increase of 18.5% on 2013, according to an analyst with research and consulting firm GlobalData.

Niharika Midha, MSc, GlobalData’s Analyst covering Medical Devices...

Écrit par The Washington Post | 12 Janvier 2015

January 8 at 3:16 PM - A French pharmaceutical company on Thursday said promising results in preliminary research using a combination of existing medications to treat Alzheimer’scould point the way toward someday combating the dementia-causing disease with a drug cocktail.

The drugs, which are not now used to treat Alzheimer’s, include acamprosate calcium, which has been prescribed...